| Primary information |
|---|
| ID | antitb_1955 |
| Peptide Name | Wollamide- B |
| Sequence | WLlVAx |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | Third residue is D-leucine and x= ornithine |
| Linear/ Cyclic | Cyclic |
| Length | 6 |
| Chirality | D |
| Nature | Cationic |
| Source | Synthetic |
| Origin | NA |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentartion | MIC > 20 μM |
| In vitro/In vivo | In vitro |
| Cell Line | HepG2 cell line |
| Inhibition Concentartion | NA |
| Cytotoxicity | Cytoxic above > 100 μM |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | cell wall pore formation |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 28423019 |
| Year of Publication | 2017 |
| 3-D Structure | NA |